Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The aminopenicillins: development and comparative properties.

D S Reeves, D W Bullock

    Infection
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Potentially dangerous misuse of the Hartford once-daily nomogram for gentamicin.

    The Journal of antimicrobial chemotherapy·2009
    Same author

    An assessment of the risks associated with the use of antibiotic resistance genes in genetically modified plants: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

    The Journal of antimicrobial chemotherapy·2004
    Same author

    Atomic-scale observation of temperature and pressure driven preroughening and roughening.

    Physical review letters·2003
    Same author

    Spatially resolved spin-injection probability for gallium arsenide.

    Science (New York, N.Y.)·2001
    Same author

    Self-medication of antibacterials without prescription (also called 'over-the-counter' use). A report of a Working Party of the British Society for Antimicrobial Chemotherapy.

    The Journal of antimicrobial chemotherapy·1999
    Same author

    Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans.

    The Journal of antimicrobial chemotherapy·1998
    Same journal

    Double agent: how Escherichia coli switches from commensal to pathogen in the urinary tract infection.

    Infection·2026
    Same journal

    Metagenomic next-generation sequencing assists in identifying neurosyphilis: a case series.

    Infection·2026
    Same journal

    Chlamydia trachomatis infection among women with spontaneous abortion in Uganda: burden, clinical presentation, and associated factors in a hospital-based cross-sectional study.

    Infection·2026
    Same journal

    Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study.

    Infection·2026
    Same journal

    Prehospital blood cultures in suspected sepsis: no need to wait until hospital arrival!

    Infection·2026
    Same journal

    Epidemiological trends of invasive Streptococcus pyogenes infections in Catalonia, 2022-2024: a two-year analysis.

    Infection·2026
    See all related articles

    Aminopenicillins like amoxicillin offer fewer bowel side effects than ampicillin, but lack strong evidence of superior efficacy. Combining them with beta-lactamase inhibitors may overcome penicillinase susceptibility.

    Area of Science:

    • Pharmacology
    • Microbiology
    • Infectious Diseases

    Background:

    • Aminopenicillins, including ampicillin and amoxicillin, are crucial antibiotics.
    • Their antibacterial and pharmacological profiles are continuously evaluated for optimal clinical use.
    • Penicillinase-producing bacteria pose a significant challenge to the efficacy of these drugs.

    Purpose of the Study:

    • To compare and contrast the antibacterial and pharmacological properties of available aminopenicillins.
    • To evaluate the clinical effectiveness and side-effect profiles of amoxicillin and ampicillin pro-drug esters versus ampicillin.
    • To explore strategies for overcoming bacterial resistance to aminopenicillins.

    Main Methods:

    • Literature review comparing existing data on aminopenicillin efficacy and pharmacology.

    Related Experiment Videos

  • Analysis of clinical evidence regarding amoxicillin and ampicillin pro-drug esters.
  • Assessment of bacterial susceptibility patterns and resistance mechanisms.

    • Main Results:

    • Limited evidence suggests amoxicillin and ampicillin pro-drug esters are not significantly more effective than ampicillin for most infections, except typhoid fever.
    • These alternatives demonstrate reduced gastrointestinal side effects compared to ampicillin.
    • Modification of the aminopenicillin molecule is unlikely to resolve penicillinase susceptibility issues.

    Conclusions:

    • Amoxicillin and ampicillin pro-drug esters may be justified by their improved tolerability, despite higher costs.
    • Beta-lactamase inhibitors, such as clavulanic acid, represent a promising approach to counteract penicillinase activity.
    • Clinical trials investigating combinations of aminopenicillins with beta-lactamase inhibitors are ongoing.